Leveraging The Window Of Opportunity In Clinical Trial Recruitment

By Kwame Marfo, Market Strategy and Innovation Lead, Clinical Development

A patient’s journey through the healthcare system is fluid, making it hard to predict what pathway they’ll go down because of their treatments and schedules outside of clinical trial participation. This variability makes identifying patients for clinical trials tricky: If you’re only looking at the healthcare providers and sites where you expect to find eligible patients, you won’t be able to identify those on a circuitous care pathway. This may be a sizable number of patients, or in the case of rare diseases, it may even represent the majority, depending on the therapeutic area.

By identifying key factors that impact patient enrollment, researchers and healthcare providers can create more effective recruitment strategies. Fortunately, access to real-world evidence (RWE) now makes it possible to identify potential trial participants, wherever they are. Gain a better understanding of how data-driven insights and proactive outreach can help ensure successful trial recruitment and improve patient outcomes.